R. Michael Carruthers
Equibles does not estimate personal net worth.
Get an email with a short summary when Edgewise Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get EWTX alertsAbout R. Michael Carruthers
R. Michael Carruthers is recorded as CFO at Edgewise Therapeutics, Inc. (EWTX). The newest filing on record that lists R. Michael Carruthers as CFO at Edgewise Therapeutics, Inc. (EWTX) is dated April 23, 2026. Edgewise Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that R. Michael Carruthers retired as Chief Financial Officer, effective November 10, 2025. The same filing states: “Mr. Carruthers' decision was not the result of any disagreement with the Company.” Edgewise Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edgewise Therapeutics, Inc. includes Kevin Koch (CEO and Board Member), Michael P. Nofi (CFO), Behrad Derakhshan (COO) and 5 others.
“Mr. Nofi will succeed the Company's current Chief Financial Officer, Michael Carruthers, who notified the Company on November 10, 2025 that he intends to retire, effective immediately.”
“Mr. Carruthers' decision was not the result of any disagreement with the Company.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 23, 2026
-
Start not stated–2025-11-10
Company network
Leadership on record at Edgewise Therapeutics, Inc.
- Kevin Koch CEO, Board Member
- Michael P. Nofi CFO
- Behrad Derakhshan COO
- Alan Russell Board Member
- Christopher Martin Board Member
- Dr. Jonathan Fox Board Member
- Jonathan Root Board Member
- Laura Brege Board Member
Recent activity
-
Executive change Retired: Chief Financial Officer
“Mr. Carruthers' decision was not the result of any disagreement with the Company.”
Edgewise Therapeutics, Inc. (EWTX)